中华皮肤科杂志 ›› 2022, Vol. 55 ›› Issue (7): 596-598.doi: 10.35541/cjd.20200765

• 研究报道 • 上一篇    下一篇

超声联合4-羟苯基维胺微泡对瘢痕疙瘩成纤维细胞Ⅰ型胶原蛋白α1链表达的影响

李周娜    金玟言    金哲虎   

  1. 延边大学附属医院皮肤科,延吉  133000
  • 收稿日期:2020-07-31 修回日期:2021-08-11 发布日期:2022-07-05
  • 通讯作者: 金哲虎 E-mail:jinzh_621@163.com
  • 基金资助:
    国家自然科学基金项目(81960561);吉林省教育厅科研项目(JJKH20191148KJ);延边大学科研项目[延大科合字(2018)38号]

Effect of ultrasound combined with 4-hydroxyphenyl-retinamide lipid microbubbles on type Ⅰ collagen α1 chain expression in keloid-derived fibroblasts

Li Zhouna, Jin Wenyan, Jin Zhehu   

  1. Department of Dermatology, Yanbian University Hospital, Yanji 133000, Jilin, China
  • Received:2020-07-31 Revised:2021-08-11 Published:2022-07-05
  • Contact: Jin Zhehu E-mail:jinzh_621@163.com
  • Supported by:
    National Natural Science Foundation of China (81960561); Scientific Research Project of the Education Department of Jilin Province (JJKH20191148KJ); Scientific Research Project of Yanbian University (YBU[2018]38)

摘要: 【摘要】 目的 探讨超声联合4-羟苯基维胺(4-HPR)微泡对瘢痕疙瘩成纤维细胞(KF)Ⅰ型胶原蛋白α1链(COL1A1)表达的影响。方法 体外培养KF,分为对照组、15 mg/L 4-HPR微泡组和超声联合15 mg/L 4-HPR微泡组,处理24 h后,运用逆转录PCR(RT-PCR)和Western印迹法分别测定各组KF中COL1A1 mRNA及其蛋白的表达。结果 对照组、4-HPR微泡组和超声联合4-HPR微泡组 COL1A1 mRNA相对表达量分别为1.00 ± 0.18、0.69 ± 0.15和0.35 ± 0.18,COL1A1蛋白相对表达水平为0.93 ± 0.03、0.74 ± 0.07和0.44 ± 0.06。4-HPR微泡组和超声联合4-HPR微泡组COL1A1 mRNA和蛋白表达水平均明显低于对照组,差异均有统计学意义(P < 0.05或0.001);而超声联合4-HPR微泡组COL1A1 mRNA和蛋白表达水平均显著低于4-HPR微泡组(均P < 0.05)。结论 超声联合4-HPR微泡对KF中COL1A1 mRNA及蛋白的表达有明显抑制作用。

关键词: 瘢痕疙瘩, 胶原Ⅰ型, 维甲酸, 超声处理, 4-羟苯基维胺, Ⅰ型胶原蛋白α1链, 微泡

Abstract: 【Abstract】 Objective To investigate the effect of ultrasound combined with 4-hydroxyphenyl-retinamide (4-HPR) lipid microbubbles on type Ⅰ collagen α1 chain (COL1A1) protein expression in keloid-derived fibroblasts. Methods In vitro cultured keloid-derived fibroblasts were divided into 3 groups: control group receiving conventional culture with incomplete Dulbecco′s modified Eagle′s medium (DMEM), 4-HPR lipid microbubble group cultured with incomplete DMEM containing 15 mg/L 4-HPR lipid microbubbles, and ultrasound + 4-HPR lipid microbubble group cultured with incomplete DMEM containing 15 mg/L 4-HPR lipid microbubbles under ultrasound treatment. After 24-hour treatment, reverse transcription (RT)-PCR and Western blot analysis were performed to determine the mRNA and protein expression of COL1A1 in keloid-derived fibroblasts in each group. Intergroup comparison was carried out by using t test. Results The mRNA relative expression level of COL1A1 was 1.00 ± 0.18, 0.69 ± 0.15 and 0.35 ± 0.18 in the control group, 4-HPR lipid microbubble group and ultrasound + 4-HPR lipid microbubble group respectively, and the protein relative expression level of COL1A1 was 0.93 ± 0.03, 0.74 ± 0.07 and 0.44 ± 0.06 in the above 3 groups respectively. Moreover, the mRNA and protein expression of COL1A1 was significantly lower in the 4-HPR lipid microbubble group and ultrasound + 4-HPR lipid microbubble group than in the control group (P < 0.05 or 0.001), and lower in the ultrasound + 4-HPR lipid microbubble group than in the 4-HPR lipid microbubble group (P < 0.05). Conclusion Ultrasound combined with 4-HPR lipid microbubbles could markedly inhibit the mRNA and protein expression of COL1A1 in keloid-derived fibroblasts.

Key words: Keloid, Collagen type I, Tretinoin, Sonication, 4-Hydroxyphenyl-retinamide, COL1A1, Microbubble